Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
10/2009
10/22/2009WO2009128479A1 Imidazoline derivative
10/22/2009WO2009128395A1 Bone formation promoter comprising 2-aminophenol or derivative thereof as active ingredient
10/22/2009WO2009128360A1 Therapeutic agent for diabetes
10/22/2009WO2009128262A1 Quinolone derivative and use thereof
10/22/2009WO2009097113A3 Oxazole and thiazole compounds as b-catenin modulators and uses thereof
10/22/2009WO2002087504A9 Methods for inhibiting tumor cell proliferation
10/22/2009US20090264529 Activators of peroxisome proliferator-activated receptors
10/22/2009US20090264519 Insulin sensitivity improving agent
10/22/2009US20090264506 Delivery of polynucleotide agents to the central nervous system
10/22/2009US20090264505 Methods and compositions for rnai mediated inhibition of gene expression in mammals
10/22/2009US20090264497 Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor
10/22/2009US20090264468 Methods for treating a disease in which Rho kinase is involved
10/22/2009US20090264462 Kappa opioid receptor ligands
10/22/2009US20090264443 Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264419 CYCLIC MALONAMIDES AS INHIBITORS OF Abeta PROTEIN PRODUCTION
10/22/2009US20090264397 Highly fluorinated oils and surfactants and methods of making and using same
10/22/2009US20090264370 Polypeptides homologous to vegf and bmp1
10/22/2009US20090264291 Compositions comprising anti-proliferative agents and use thereof
10/22/2009US20090263916 Antagonists of HMG1 for treating inflammatory conditions
10/22/2009US20090263784 Three-dimensional structure of prostaglandin d synthase and utilization thereof
10/22/2009US20090263507 Biological markers and response to treatment for pain, inflammation, neuronal or vascular injury and methods of use
10/22/2009US20090263488 Pressurised metered dose inhalers containing solutions of beta-2 agonists
10/22/2009US20090263484 Tissue Engineering Devices and Methods for Luminal Organs
10/22/2009US20090263480 Taste-masked pharmaceutical compositions prepared by coacervation
10/22/2009US20090263455 Dexamethasone Formulations in a Bioegradable Material
10/22/2009US20090263445 Medical devices comprising spray dried microparticles
10/22/2009US20090263408 Formulation and presentation of medicaments
10/22/2009US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009US20090263322 Octahydro-indolizine and quinolizine and hexahydro-pyrrolizines
10/22/2009US20090263320 Peptide-Based Compounds
10/22/2009CA2721453A1 Sparc anti-inflammatory activity and uses thereof
10/22/2009CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/21/2009EP2110434A1 Type-1 cytokine receptor GLM-R
10/21/2009EP2110141A1 Protective agent for retinal nerve or optic nerve
10/21/2009EP2110138A1 Dosages for treatment of anti-erbB2 antibodies
10/21/2009EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009EP2109614A1 Enantioselective synthesis of 6-amino-7-hydroxy-4, 5, 6, 7-tetrahydro-imidazo [4, 5, 1-jk][1]-benzazepin-2 [1h]-one and zilpaterol
10/21/2009EP1515724B1 Mitotic kinesin inhibitors
10/21/2009EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009EP1463506B1 Substituted quinazoline derivatives as inhibitors of aurora kinases
10/21/2009EP1450811B1 Compounds specific to adenosine A1 and A3 receptors and uses thereof
10/21/2009EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009EP1448526B1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
10/21/2009EP1423413B1 Peptidic compounds selectively binding to p-selectin
10/21/2009EP1415154B1 Control of growth and repair of gastro-intestinal tissues by gastrokines
10/21/2009EP1397386B1 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/21/2009EP1383778B1 Agonists and antagonists of sphingosine-1-phosphate receptors
10/21/2009EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009EP1169462B1 Oil comprising brassicastanol
10/21/2009EP1162968B1 Epigallocatechin-gallate for inhibiting angiogenesis
10/21/2009EP1047436B1 N-acetylhomotaurinates for use in treating hyperkinesias
10/21/2009EP0959899B9 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION
10/21/2009CN101563093A Grifola frondosa-origin substance having antiinfluenza virus activity and method of producing the same
10/21/2009CN101560214A 4-amino-6-phenyl-pyrrolo[2, 3-d]pyrimidine derivatives
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009CN101559216A Amino acid composition capable of protecting kidney and liver as well as promoting growth for animal and preparation technique thereof
10/21/2009CN101559200A Traditional Chinese medicine for treating pain in chest
10/21/2009CN101559065A Choerospondias extractive, preparation and application of phenol compound contained in choerospondias extractive
10/21/2009CN101559064A Medicament capable of protecting cell membrane
10/21/2009CN101559051A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on melanoma
10/21/2009CN101559050A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on immune system
10/21/2009CN100552016C Bifidobacterium in treatment of inflammatory disease
10/21/2009CN100551370C Use of Ranolazine in preparing pharmaceutical composition for treating diabetes
10/21/2009CN100551364C Medicine use of 3 (3 nitryl-4-hydroxy)phenyl acrylate in preparing medicine for controlling xanthine oxidase
10/21/2009CN100551357C Anti-fatigue medicine prepared from coriolus versicolor mycelium
10/21/2009CN100551348C External compositions for the skin
10/20/2009US7605274 precipitating crystalline form from solvent solution using water as an antisolvent
10/20/2009US7605179 administering vitamin k derivatives for prophylaxis of neurodegenerative diseases associated with protein aggregation or neurofibrillary tangles
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605140 Endothelial growth factors; antiischemic agents; neovascularization
10/20/2009US7604989 Prevention or delaying apoptosis in recombinant cell; obtainceks transforme with nucleotide sequences coding antiapoptotic agents, express sequences, monitor adjustment in apotosis activity
10/20/2009US7604949 For skin lightening or darkening; cell-free; drug screening
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2492854C Sustained-release tablet composition of pramipexole
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2450122C Novel heterocyclic antibacterial compounds
10/20/2009CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009CA2380986C Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
10/20/2009CA2378428C Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
10/20/2009CA2360110C Sustained release salts of pharmaceutically active peptides and their production
10/20/2009CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/20/2009CA2336663C Coumarin and related aromatic-based polymeric prodrugs
10/20/2009CA2330128C Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
10/20/2009CA2250085C Modulators of tnf receptor associated factor (traf), their preparation and use
10/20/2009CA2168937C Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
10/15/2009WO2009126858A2 Materials and methods for improved immunoglycoproteins
10/15/2009WO2009126725A1 Method of modulating neovascularization
10/15/2009WO2009126691A1 Inhibitors of fatty acid amide hydrolase
10/15/2009WO2009125861A1 Cysteine protease inhibitor
10/15/2009WO2009125853A1 Homocysteine synthase inhibitor
10/15/2009WO2009125841A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material
10/15/2009WO2009125819A1 Aminosugar compound and process for production thereof
10/15/2009WO2009125804A1 Screening method
10/15/2009WO2009125126A2 Functionalized polysiloxanes, method of preparing same and uses thereof
10/15/2009WO2009124420A1 Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090258935 Hybrid adeno-retroviral vector for the transfection of cells
10/15/2009US20090258922 Compound exhibiting pgd2 receptor antagonist
1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 1564